| Literature DB >> 31010981 |
Jun-Ichi Suto1, Misaki Kojima2.
Abstract
OBJECTIVE: Testicular growth and development are strongly influenced by androgen. Although both testis weight and plasma testosterone level are inherited traits, the interrelationship between them is not fully established. Males of DDD/Sgn (DDD) mice are known to have extremely heavy testes and very high plasma testosterone level among inbred mouse strains. We dissected the genetic basis of testis weight and analyzed the potential influence of plasma testosterone level in DDD mice.Entities:
Keywords: DDD/Sgn Mice; Quantitative Trait Loci (QTL) Mapping; Testis Weight; Testosterone Level; Whole-Exome Sequence Analysis
Year: 2019 PMID: 31010981 PMCID: PMC6819690 DOI: 10.5713/ajas.18.0783
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Figure 1A histogram showing the distribution of testis weight in 297 F2 mice (data from BD [♀B6×♂DDD] F2 and DB [♀DDD×♂B6] F2 mice are combined). The mean±SEM is 255.8±1.7 mg (The mean±SEM testis weight in BD F2 mice is 257.0±2.3 mg and that in BD F2 mice is 254.6±2.4 mg. The difference was not statistically significant). The average testis weight of parental B6 and DDD strains are indicated by arrows. SEM, standard error of the mean.
Figure 2Genome-wide LOD score plot for testis weight when the lineage effect was included as an additive covariate (solid lines) and when the body weight was included as an additive covariate (dashed lines). The x-axis represents chromosomal and microsatellite marker positions and the y-axis represents LOD scores. Horizontal broken lines indicate the genome-wide threshold LOD score for significant (p<0.05) and suggestive (p<0.63) linkage. Threshold LOD scores for significant and suggestive quantitative trait loci were 3.56 and 2.10 for autosomes and 2.73 and 1.48 for Chr X, respectively. LOD, logarithm of the odds.
Significant and suggestive QTL identified by the genome-wide scan of F2 mice
| QTL | Chr | Peak cM | 95% CI | LOD | Nearest marker | High strain |
|---|---|---|---|---|---|---|
| 1 | 57.5 | 49.5–72.5 | DDD | |||
| 4 | 33.1 | 8.1–61.1 | 3.3 | DDD | ||
| 7 | 2.0 | 2.0–20.2 | 2.7 | DDD | ||
| 8 | 41.5 | 14.5–50.1 | DDD | |||
| 10 | 61.5 | 35.5–66.7 | 2.2 | B6 | ||
| 14 | 32.3 | 16.3–57.3 | DDD | |||
| 17 | 36.1 | 17.1–60.7 | DDD | |||
| By including | ||||||
| 5 | 41.6 | 17.8–72.8 | 2.5 | DDD | ||
| By including body weight as an additive covariate | ||||||
| | 7 | 2.0 | 2.0–16.0 | DDD | ||
| 18 | 45.9 | 28.9–55.9 | 2.4 | DDD | ||
QTL, quantitative trait loci; CI, confidence interval; LOD, logarithm of the odds.
Lineage effect was included as an additive covariate.
QTL symbols were assigned if they were significant, or if they were suggestive but identified as significant at least once previously in different genetic crosses.
95% CI was defined by a 1.5–LOD drop.
LOD scores for significant QTL are indicated in bold.
High strain-derived alleles were associated with higher testis weight.
Multiple regression analysis for testis weight
| Mice | Chr (cM) | df | Variance (%) | F value |
|---|---|---|---|---|
| All F2 | Chr1@57.5 | 2 | 13.7 | 33.0 |
| Chr4@33.1 | 2 | 2.0 | 4.8 | |
| Chr7@2.0 | 2 | 3.1 | 7.4 | |
| Chr8@41.5 | 2 | 4.9 | 11.8 | |
| Chr10@61.5 | 2 | 1.8 | 4.4 | |
| Chr14@32.3 | 2 | 5.6 | 13.5 | |
| Chr17@37.1 | 2 | 4.5 | 10.7 | |
| Total | 14 | 41.4 | - | |
| F2L | Chr1@52.5 | 2 | 12.7 | 10.5 |
| Chr10@64.5 | 2 | 5.6 | 4.7 | |
| Chr14@53.3 | 2 | 8.3 | 6.9 | |
| Total | 6 | 29.9 | - | |
| F2H | Chr1@68.5 | 2 | 12.0 | 16.4 |
| Chr4@33.1 | 2 | 2.7 | 3.7 | |
| Chr8@45.5 | 2 | 5.8 | 8.0 | |
| Chr17@52.1 | 2 | 9.0 | 12.4 | |
| Total | 8 | 39.8 | - |
Degrees of freedom.
Percentage of total F2 phenotypic variance.
Lineage effect was included as a covariate.
Significant and suggestive QTL identified by the genome-wide scan of separate F2 mice
| Mice | QTL | Chr | Peak cM | 95% CI | LOD |
|---|---|---|---|---|---|
| F2L | 1 | 52.5 | 16.5–72.5 | ||
| 10 | 64.5 | 45.5–66.7 | 2.4 | ||
| 14 | 53.3 | 22.3–62.3 | 2.8 | ||
| F2H | 1 | 68.5 | 51.5–75.5 | ||
| 4 | 33.1 | 15.1–52.1 | 3.3 | ||
| 8 | 45.5 | 15.5–58.5 | |||
| 17 | 52.1 | 25.1–60.7 |
QTL, quantitative trait loci; CI, confidence interval; LOD, logarithm of the odds.
QTL symbols were assigned if they were significant, or if they were suggestive but identified as significant at least once previously in different genetic crosses.
95% CI was defined by a 1.5–LOD drop.
LOD scores for significant QTL are indicated in bold.
Figure 3Genome-wide LOD score plot of the QTL for testis weight when the F2H (solid lines) and F2L (dashed lines) mice were analyzed separately. The x-axis represents the chromosomal and microsatellite marker position, and the y-axis represents the LOD score. Horizontal broken lines indicate the genome-wide threshold LOD score for significant (p<0.05) and suggestive (p<0.63) linkage. Threshold LOD scores for significant and suggestive QTL were 3.37 and 2.08 for autosomes and 2.72 and 1.50 for Chr X, respectively. LOD, logarithm of the odds; QTL, quantitative trait loci.
Figure 4Comparison of allele effect of significant QTL among all F2, F2L, and F2H mice. The x-axis represents the genotype at the microsatellite marker nearest QTL, and the y-axis represents average testis weight. Mice with different superscripts denote the presence of significant difference. Statistical difference between mice with three genotypes within each F2 group (i.e., F2 all, F2L, and F2H) was identified by Tukey–Kramer honestly significant difference tests. Error bars indicate standard error of means. QTL, quantitative trait loci.
Candidate genes, mutant phenotypes, and nsSNV identified for candidate genes of significant QTL
| Chr | Position cM | Gene | Testis weight in mutants | Location | Nucleotide change | Amino acid change | db SNP ID |
|---|---|---|---|---|---|---|---|
| 1 | 57.91 | Decrease | - | - | - | - | |
| 57.94 | Decrease | - | - | - | - | ||
| 58.24 | Increase | - | - | - | - | ||
| 61.45 | Decrease | - | - | - | - | ||
| 67.71 | Decrease | Chr 1: 156262881 | c.2594C>G | p.Pro865Arg | rs49650703 | ||
| Chr 1: 156263413 | c.2495C>T | p.Ala832Val | rs13476193 | ||||
| Chr 1: 156267355 | c.2177G>A | p.Gly726Glu | rs48483855 | ||||
| Chr 1: 156270646 | c.2080G>A | p.Asp694Asn | rs30769841 | ||||
| Chr 1: 156285523 | c.1186A>G | p.Thr396Ala | rs31654838 | ||||
| Chr 1: 156301806 | c.333A>G | p.Ile111Met | rs32356404 | ||||
| 71.56 | Decrease | - | - | - | - | ||
| 8 | 18.75 | Decrease | Chr 8: 31818081 | c.2050T>A | p.Leu684Ile | rs32559738 | |
| 20.59 | Decrease | - | - | - | - | ||
| 23.89 | Decrease | - | - | - | - | ||
| 26.87 | Decrease | - | - | - | - | ||
| 40.45 | Decrease | Chr 8: 84176519 | c.13A>G | p.Asn5Asp | rs38027221 | ||
| 41.25 | Decrease | Chr 8: 848722541 | c.13G>A | p.Gly5Arg | rs32744209 | ||
| 14 | 18.79 | Decrease | - | - | - | - | |
| 25.36 | Decrease | - | - | - | - | ||
| 27.98 | Decrease | - | - | - | - | ||
| 36.32 | Decrease | - | - | - | - | ||
| 37.62 | Decrease | - | - | - | - | ||
| 50.09 | Increase | Chr 14: 101458822 | c.2500A>G | p.Ile834Val | rs48744612 | ||
| Chr 14: 101477059 | c.1975A>G | p.Arg659Gly | rs235588405 | ||||
| 17 | 18.57 | Decrease | Chr 17: 35028832 | c.2411C>A | p.Thr804Lys | rs33561826 | |
| Chr 17: 35031264 | c.1693A>G | p.Met565Val | rs50143709 | ||||
| 18.59 | Decrease | - | - | - | - | ||
| 18.75 | Decrease | Chr 17: 35909951 | c.85C>T | p.Pro29Ser | – | ||
| 25.86 | Decrease | - | - | - | - | ||
| 29.4 | Decrease | - | - | - | - | ||
| 58.35 | Decrease | - | - | - | - | ||
| 58.76 | Decrease | Chr 17: 88985240 | c.2009C>A | p.Pro670His | rs107828637 | ||
| Chr 17: 88985243 | c.2006A>G | p.Asn669Ser | rs108743480 | ||||
| Chr 17: 88986290 | c.959G>A | p.Ser320Asn | rs51040992 |
nsSNV, nonsynonymous single-nucleotide variation; QTL, quantitative trait loci; SNP, single nucleotide polymorphism; Kiss1, KiSS-1 metastasis-suppressor; Snrpe, small nuclear ribonucleoprotein E; Ptprv, protein tyrosine phosphatase, receptor type, V; Aspm, abnormal spindle microtubule assembly; Tdrd5, tudor domain containing 5; Slc19a2, solute carrier family 19 (thiamine transporter), member 2; Nrg1, neuregulin 1; Tex15, testis expressed gene 15; Cnot7, CCR4-NOT transcription complex, subunit 7; Ing2, inhibitor of growth family, member 2; Nanos3, nanos C2HC-type zinc finger 3; Syce2, synaptonemal complex central element protein 2; Tkt, transketolase; Otx2, orthodenticle homeobox 2; Bcl2l2, BCL-like 2; Piwil2, piwi-like RNA-mediated gene silencing 2; Fndc3a, fibronectin type III domain containing 3A; Tbc1d4, TBC1 domain family, member 4; Msh5, mutS homolog 5; Tnf, tumor necrosis factor; Atat1, alpha tubulin acetyltransferase 1; Dazl, deleted in azoospermia-like; Safb, scaffold attachment factor B; Lhcgr, luteinizing hormone/choriogonadotropin receptor; Fshr, follicle stimulating hormone receptor.
Figure 5Atat1 sequence analysis. (A) Sequencing chromatograms for Atat1 from DDD/Sgn, C57BL/6J, DH/Sgn, and CBA/N mice showing C>T polymorphism. (B) Atat1 sequence alignment from various species with the novel polymorphism in red. Atat1, alpha tubulin acetyltransferase 1.